REMIVE Trademark

Trademark Overview

On Thursday, January 29, 2004, a trademark application was filed for REMIVE with the United States Patent and Trademark Office. The USPTO has given the REMIVE trademark a serial number of 78359228. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 23, 2009. This trademark is owned by Glaxo Group Limited. The REMIVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the prevention, treatment and/or alleviation of migraine and other forms of headache which are distributed by prescription only in tablet form for oral administration
remive

General Information

Serial Number78359228
Word MarkREMIVE
Filing DateThursday, January 29, 2004
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 23, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 9, 2004

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the prevention, treatment and/or alleviation of migraine and other forms of headache which are distributed by prescription only in tablet form for oral administration

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 9, 2004
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB6 ONN
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB6 ONN
GB

Trademark Events

Event DateEvent Description
Monday, February 23, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 23, 2009ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 2, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 2, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 21, 2008EXTENSION 3 GRANTED
Friday, July 11, 2008EXTENSION 3 FILED
Monday, July 21, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 10, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 11, 2008TEAS EXTENSION RECEIVED
Friday, December 14, 2007EXTENSION 2 GRANTED
Monday, November 26, 2007EXTENSION 2 FILED
Monday, November 26, 2007TEAS EXTENSION RECEIVED
Thursday, September 6, 2007EXTENSION 1 GRANTED
Thursday, June 14, 2007EXTENSION 1 FILED
Thursday, June 14, 2007TEAS EXTENSION RECEIVED
Tuesday, June 12, 2007ASSIGNED TO EXAMINER
Wednesday, May 23, 2007ASSIGNED TO EXAMINER
Thursday, February 8, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 23, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 24, 2006PAPER RECEIVED
Thursday, December 7, 2006OPPOSITION TERMINATED NO. 999999
Thursday, December 7, 2006OPPOSITION DISMISSED NO. 999999
Tuesday, May 24, 2005OPPOSITION INSTITUTED NO. 999999
Tuesday, November 9, 2004EXTENSION OF TIME TO OPPOSE RECEIVED
Wednesday, February 23, 2005NOTICE OF ALLOWANCE CANCELLED
Tuesday, February 1, 2005NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 9, 2004PUBLISHED FOR OPPOSITION
Wednesday, October 20, 2004NOTICE OF PUBLICATION
Tuesday, September 14, 2004LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, September 9, 2004ASSIGNED TO LIE
Sunday, August 22, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, August 21, 2004ASSIGNED TO EXAMINER
Monday, February 9, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

remive prescription distributed which only tablet administration oral form headache forms